Antibacterial triphosphates: different use of nucleoside analogues

August 15, 2022|Antivirals | 5 Min Read

Antibacterial triphosphates: different use of nucleoside analogues1 In the last years, and especially during the SARS-Co-2 pandemic, giant efforts were devoted to designing, synthesising and studying antiviral agents. On the […]

Read More

Santiago’s Case Study: Antiviral Kit

April 5, 2022|Antivirals | 4 Min Read

Research in a time of COVID-19 When a thousand people worldwide suffered from lethal coronavirus (COVID-19) in 2020, we came up with an ambitious project to contribute to the worldwide […]

Read More

New Nucleoside Triphosphates with Antiviral Activity

February 3, 2022|Antivirals, Triphosphates | 5 Min Read

Nucleoside triphosphates with antiviral activity Viruses are causing many troubles in our lives these days. They cause many serious diseases (some of them even deadly) such as cold, influenza, EBOLA, […]

Read More

Antiviral drugs

December 13, 2021|Antivirals, Nucleosides, Triphosphates | 8 Min Read

Viruses are pathogens occurring all around us that can be fought with antiviral drugs. Viruses are the cause of a large number of diseases, many of which are deadly – […]

Read More


November 19, 2021|Antivirals, Nucleosides, Triphosphates, Uncategorized | 3 Min Read
Molnupiravir is a new potential drug against the SARS-CoV-2 infectious virus.   To this date, all medications against SARS-CoV-2 are administered only by infusion and only in severe disease cases [...]
Read More

Fighting viruses with nucleotide prodrugs at Santiago Lab

October 11, 2021|Antivirals, Nucleosides | 4 Min Read

During the course of the last decades, outstanding efforts were devoted to design and develop nucleotide prodrugs to be employed as potential therapeutic agents, especially for the treatment of human […]

Read More